On Friday, Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) was -24.37% drop from the session before settling in for the closing price of $26.67. A 52-week range for TNXP has been $6.76 – $1100.80.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 5.99%. When this article was written, the company’s average yearly earnings per share was at 93.27%. With a float of $6.43 million, this company’s outstanding shares have now reached $6.43 million.
Let’s determine the extent of company efficiency that accounts for 81 employees. In terms of profitability, gross margin is 23.07%, operating margin of -770.2%, and the pretax margin is -1287.82%.
Tonix Pharmaceuticals Holding Corp (TNXP) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Tonix Pharmaceuticals Holding Corp stocks. The insider ownership of Tonix Pharmaceuticals Holding Corp is 0.00%, while institutional ownership is 2.48%.
Tonix Pharmaceuticals Holding Corp (TNXP) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -2.68 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 93.27% per share during the next fiscal year.
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) Trading Performance Indicators
You can see what Tonix Pharmaceuticals Holding Corp (TNXP) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 6.04. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 12.86.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -29.46, a number that is poised to hit -3.09 in the next quarter and is forecasted to reach -4.67 in one year’s time.
Technical Analysis of Tonix Pharmaceuticals Holding Corp (TNXP)
Looking closely at Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP), its last 5-days average volume was 2.73 million, which is a jump from its year-to-date volume of 1.68 million. As of the previous 9 days, the stock’s Stochastic %D was 44.88%. Additionally, its Average True Range was 4.45.
During the past 100 days, Tonix Pharmaceuticals Holding Corp’s (TNXP) raw stochastic average was set at 10.88%, which indicates a significant decrease from 30.69% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 245.72% in the past 14 days, which was lower than the 273.18% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $19.02, while its 200-day Moving Average is $33.23. However, in the short run, Tonix Pharmaceuticals Holding Corp’s stock first resistance to watch stands at $24.15. Second resistance stands at $28.14. The third major resistance level sits at $30.50. If the price goes on to break the first support level at $17.80, it is likely to go to the next support level at $15.44. Now, if the price goes above the second support level, the third support stands at $11.45.
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) Key Stats
There are 6,435K outstanding shares of the company, which has a market capitalization of 129.79 million. As of now, sales total 10,090 K while income totals -130,040 K. Its latest quarter income was 2,580 K while its last quarter net income were -22,110 K.
